Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte ; volume:20 ; number:1 ; day:7 ; month:5 ; year:2021 ; pages:1-16 ; date:12.2021
Cardiovascular diabetology ; 20, Heft 1 (7.5.2021), 1-16, 12.2021
- Urheber
-
D’Onofrio, Nunzia
Scisciola, Lucia
Sardu, Celestino
Trotta, Maria Consiglia
Feo, Marisa De
Maiello, Ciro
Mascolo, Pasquale
Micco, Francesco De
Turriziani, Fabrizio
Municinò, Emilia
Monetti, Pasquale
Lombardi, Antonio
Napolitano, Maria Gaetana
Marino, Federica Zito
Ronchi, Andrea
Grimaldi, Vincenzo
Hermenean, Anca
Rizzo, Maria Rosaria
Barbieri, Michelangela
Franco, Renato
Campobasso, Carlo Pietro
Napoli, Claudio
Municinò, Maurizio
Paolisso, Giuseppe
Balestrieri, Maria Luisa
Marfella, Raffaele
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-021-01286-7
- URN
-
urn:nbn:de:101:1-2021091022154858329714
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- D’Onofrio, Nunzia
- Scisciola, Lucia
- Sardu, Celestino
- Trotta, Maria Consiglia
- Feo, Marisa De
- Maiello, Ciro
- Mascolo, Pasquale
- Micco, Francesco De
- Turriziani, Fabrizio
- Municinò, Emilia
- Monetti, Pasquale
- Lombardi, Antonio
- Napolitano, Maria Gaetana
- Marino, Federica Zito
- Ronchi, Andrea
- Grimaldi, Vincenzo
- Hermenean, Anca
- Rizzo, Maria Rosaria
- Barbieri, Michelangela
- Franco, Renato
- Campobasso, Carlo Pietro
- Napoli, Claudio
- Municinò, Maurizio
- Paolisso, Giuseppe
- Balestrieri, Maria Luisa
- Marfella, Raffaele
- SpringerLink (Online service)
Ähnliche Objekte (12)
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control
Binding affinity improvement analysis of multiple-mutant Omicron on 2019-nCov to human ACE2 by in silico predictions
Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study
Enrichment and analysis of glycated proteins
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control
Binding affinity improvement analysis of multiple-mutant Omicron on 2019-nCov to human ACE2 by in silico predictions
Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study
Enrichment and analysis of glycated proteins
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Coronaviruses Use ACE2 Monomers as Entry‐Receptors
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
Glycated hemoglobin and glycated albumin in patients with diabetes undergoing hemodiafiltration
Glycated Haemoglobin and Glycated Albumin: Evaluation of Different Methods in Diabetic Control
Binding affinity improvement analysis of multiple-mutant Omicron on 2019-nCov to human ACE2 by in silico predictions
Inverse correlation of free triiodothyronine with glycated albumin and the glycated albumin/glycated hemoglobin ratio in hemodialysis patients: a cross-sectional study
Enrichment and analysis of glycated proteins
APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients
P21-activated kinase 1 (PAK1)-mediated cytoskeleton rearrangement promotes SARS-CoV-2 entry and ACE2 autophagic degradation
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2